Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir
about
Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients.Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy.Plasma cytokine profiles in HIV-1 infected patients developing neuropathic symptoms shortly after commencing antiretroviral therapy: a case-control study.Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected menRelaxation effect of abacavir on rat basilar arteries.Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis.Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study.Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women.Short communication: initiation of an abacavir-containing regimen in HIV-infected adults is associated with a smaller decrease in inflammation and endothelial activation markers compared to non-abacavir-containing regimensInflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: impact of abacavir and zidovudineTobacco use and cessation in HIV-infected individualsRelationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy.IL-4 and IL-6 levels and adipose tissue distribution in HIV-1 patients under antiretroviral therapy.Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study.
P2860
Q31118978-36080900-DC18-47C6-8D88-2F7EFCD33E46Q33749579-A5AC2815-CAAA-4EC8-8BB4-2599E0AF392BQ34039680-B8038E0E-FA46-4076-8F87-738C68D90950Q35089902-A264A72C-EBCE-43E7-AD4F-A3E776990526Q35587294-A324FF15-E0D7-45E3-BFEA-54137064D3ACQ35597616-0E490BD5-576A-44F2-B74C-174ED81491E7Q35672526-3092D6DB-F3AA-41D9-9AAA-15713BEF85CEQ36116238-E134F510-9B8F-498C-9197-F5612064D836Q36404094-78CFD3DF-BCB4-44C7-B4B8-C8551CE87331Q36419549-EC6A7D8E-74D5-49F1-B73E-3D6D1B0DDE06Q36578046-AE7E4DFB-5502-4626-BB46-CE5BDD570D50Q36917137-F0AD3F8A-A533-4E42-8323-D1F16DDC4FC1Q37041288-1E255AD6-6C67-406F-BF35-8171DAE3CC35Q37589696-EB836E6F-2BA0-4B6F-B47A-C33189DF16A2Q41461481-BCAA4707-CD22-40DD-93DB-E45955586E9CQ42609996-E8CBBE7C-5194-4B91-86BD-C2ABB9BEDF36
P2860
Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Early changes in inflammatory ...... apy with abacavir or tenofovir
@ast
Early changes in inflammatory ...... apy with abacavir or tenofovir
@en
type
label
Early changes in inflammatory ...... apy with abacavir or tenofovir
@ast
Early changes in inflammatory ...... apy with abacavir or tenofovir
@en
prefLabel
Early changes in inflammatory ...... apy with abacavir or tenofovir
@ast
Early changes in inflammatory ...... apy with abacavir or tenofovir
@en
P2093
P2860
P356
P1476
Early changes in inflammatory ...... apy with abacavir or tenofovir
@en
P2093
Consuelo Tormo
Félix Gutiérrez
Inmaculada Jarrin
Natalia García
Sergio Padilla
P2860
P2888
P356
10.1186/1471-2334-11-40
P577
2011-02-04T00:00:00Z
P5875
P6179
1039604287